 | • レポートコード：MRC2301F0010 • 出版社/出版日：Transparency Market Research / 2022年11月11日 • レポート形態：英文、PDF、250ページ • 納品方法：Eメール • 産業分類：医療機器 |
| Single User | ￥869,250 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,319,250 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,769,250 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| トランスペアレンシー・マーケット・リサーチ社の当調査資料では、世界の神経血管カテーテル市場について総合的に調査・分析を行い、エグゼクティブサマリー、市場概要、市場背景、種類別（マイクロカテーテル、バルーンカテーテル、アクセスカテーテル、塞栓カテーテル、その他）分析、用途別（塞栓性脳卒中、脳動脈瘤、動静脈奇形、その他）分析、エンドユーザー別（病院、診療所、外来手術センター、診断センター）分析、地域別（北米、中南米、ヨーロッパ、南アジア、東アジア、オセアニア、中東/アフリカ）分析、競争状況、企業情報などの項目を掲載しています。なお、当市場の主要企業には、Medtronic、BALT USA LLC、DePuy Synthes、Biomerics、Zeus Indutsrial Products, INC.、Raumedic AG、Concentric Medical, Inc、Creganna Medical、Vegamedical.eu、Strykerなどが含まれています。 ・エグゼクティブサマリー ・市場概要 ・市場背景 ・世界の神経血管カテーテル市場規模：種類別 - マイクロカテーテルの市場規模 - バルーンカテーテルの市場規模 - アクセスカテーテルの市場規模 - 塞栓カテーテルの市場規模 - その他種類の市場規模 ・世界の神経血管カテーテル市場規模：用途別 - 塞栓性脳卒中における市場規模 - 脳動脈瘤における市場規模 - 動静脈奇形における市場規模 - その他用途における市場規模 ・世界の神経血管カテーテル市場規模：エンドユーザー別 - 病院における市場規模 - 診療所における市場規模 - 外来手術センターにおける市場規模 - 診断センターにおける市場規模 ・世界の神経血管カテーテル市場規模：地域別 - 北米の神経血管カテーテル市場規模 - 中南米の神経血管カテーテル市場規模 - ヨーロッパの神経血管カテーテル市場規模 - 南アジアの神経血管カテーテル市場規模 - 東アジアの神経血管カテーテル市場規模 - オセアニアの神経血管カテーテル市場規模 - 中東/アフリカの神経血管カテーテル市場規模 ・競争状況 ・企業情報 |
Neurovascular Catheter Market – Scope of Report
TMR’s report on the global neurovascular catheter market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global neurovascular catheter market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global neurovascular catheter market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the neurovascular catheter market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global neurovascular catheter market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global neurovascular catheter market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global neurovascular catheter market.
The report delves into the competitive landscape of the global neurovascular catheter market. Key players operating in the global neurovascular catheter market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global neurovascular catheter market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market neurovascular catheter.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Investment Feasibility Matrix
3.4. Value Chain Analysis
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
4. Global Neurovascular Catheters Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Neurovascular Catheters Market Analysis 2017-2021 and Forecast 2022-2032, By Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Type, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Type, 2022-2032
5.3.1. Microcatheters
5.3.2. Balloon Catheters
5.3.3. Access Catheters
5.3.4. Embolization Catheters
5.3.5. Other types
5.4. Y-o-Y Growth Trend Analysis By Type, 2017-2021
5.5. Absolute $ Opportunity Analysis By Type, 2022-2032
6. Global Neurovascular Catheters Market Analysis 2017-2021 and Forecast 2022-2032, By End Use
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By End Use, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End Use, 2022-2032
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Ambulatory Surgical Centers
6.3.4. Diagnostic Centers
6.4. Y-o-Y Growth Trend Analysis By End Use, 2017-2021
6.5. Absolute $ Opportunity Analysis By End Use, 2022-2032
7. Global Neurovascular Catheters Market Analysis 2017-2021 and Forecast 2022-2032, By Application
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022-2032
7.3.1. Embolic Stroke
7.3.2. Brain Aneurysm
7.3.3. Arteriovenous Malformations
7.3.4. Other Applications
7.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021
7.5. Absolute $ Opportunity Analysis By Application, 2022-2032
8. Global Neurovascular Catheters Market Analysis 2017-2021 and Forecast 2022-2032, By End Use
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Mn) Analysis By End Use, 2017-2021
8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End Use, 2022-2032
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Ambulatory Surgical Centers
8.3.4. Diagnostic Centers
8.4. Y-o-Y Growth Trend Analysis By End Use, 2017-2021
8.5. Absolute $ Opportunity Analysis By End Use, 2022-2032
9. Global Neurovascular Catheters Market Analysis 2017-2021 and Forecast 2022-2032, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. East Asia
9.3.5. South Asia
9.3.6. Oceania
9.3.7. MEA
9.4. Market Attractiveness Analysis By Region
10. North America Neurovascular Catheters Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. U.S.
10.2.1.2. Canada
10.2.2. By Type
10.2.3. By End Use
10.2.4. By Application
10.2.5. By End Use
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Type
10.3.3. By End Use
10.3.4. By Application
10.3.5. By End Use
10.4. Key Takeaways
11. Latin America Neurovascular Catheters Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Argentina
11.2.1.4. Chile
11.2.1.5. Peru
11.2.1.6. Rest of Latin America
11.2.2. By Type
11.2.3. By End Use
11.2.4. By Application
11.2.5. By End Use
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Type
11.3.3. By End Use
11.3.4. By Application
11.3.5. By End Use
11.4. Key Takeaways
12. Europe Neurovascular Catheters Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. Italy
12.2.1.3. France
12.2.1.4. U.K.
12.2.1.5. Spain
12.2.1.6. Russia
12.2.1.7. BENELUX
12.2.1.8. Rest of Europe
12.2.2. By Type
12.2.3. By End Use
12.2.4. By Application
12.2.5. By End Use
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Type
12.3.3. By End Use
12.3.4. By Application
12.3.5. By End Use
12.4. Key Takeaways
13. East Asia Neurovascular Catheters Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Type
13.2.3. By End Use
13.2.4. By Application
13.2.5. By End Use
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Type
13.3.3. By End Use
13.3.4. By Application
13.3.5. By End Use
13.4. Key Takeaways
14. South Asia Neurovascular Catheters Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. India
14.2.1.2. Thailand
14.2.1.3. Malaysia
14.2.1.4. Indonesia
14.2.1.5. Rest of South Asia
14.2.2. By Type
14.2.3. By End Use
14.2.4. By Application
14.2.5. By End Use
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Type
14.3.3. By End Use
14.3.4. By Application
14.3.5. By End Use
14.4. Key Takeaways
15. Oceania Neurovascular Catheters Market Analysis 2017-2021 and Forecast 2022-2032, By Country
15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
15.2.1. By Country
15.2.1.1. Australia
15.2.1.2. New Zealand
15.2.2. By Type
15.2.3. By End Use
15.2.4. By Application
15.2.5. By End Use
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Type
15.3.3. By End Use
15.3.4. By Application
15.3.5. By End Use
15.4. Key Takeaways
16. MEA Neurovascular Catheters Market Analysis 2017-2021 and Forecast 2022-2032, By Country
16.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
16.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
16.2.1. By Country
16.2.1.1. GCC
16.2.1.2. Rest of MEA
16.2.2. By Type
16.2.3. By End Use
16.2.4. By Application
16.2.5. By End Use
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Type
16.3.3. By End Use
16.3.4. By Application
16.3.5. By End Use
16.4. Key Takeaways
17. Key Countries Neurovascular Catheters Market Analysis
17.1. U.S.
17.1.1. Pricing Analysis
17.1.2. Market Share Analysis, 2021
17.1.2.1. By Type
17.1.2.2. By End Use
17.1.2.3. By Application
17.1.2.4. By End Use
17.2. Canada
17.2.1. Pricing Analysis
17.2.2. Market Share Analysis, 2021
17.2.2.1. By Type
17.2.2.2. By End Use
17.2.2.3. By Application
17.2.2.4. By End Use
17.3. Brazil
17.3.1. Pricing Analysis
17.3.2. Market Share Analysis, 2021
17.3.2.1. By Type
17.3.2.2. By End Use
17.3.2.3. By Application
17.3.2.4. By End Use
17.4. Mexico
17.4.1. Pricing Analysis
17.4.2. Market Share Analysis, 2021
17.4.2.1. By Type
17.4.2.2. By End Use
17.4.2.3. By Application
17.4.2.4. By End Use
17.5. Argentina
17.5.1. Pricing Analysis
17.5.2. Market Share Analysis, 2021
17.5.2.1. By Type
17.5.2.2. By End Use
17.5.2.3. By Application
17.5.2.4. By End Use
17.6. Germany
17.6.1. Pricing Analysis
17.6.2. Market Share Analysis, 2021
17.6.2.1. By Type
17.6.2.2. By End Use
17.6.2.3. By Application
17.6.2.4. By End Use
17.7. Italy
17.7.1. Pricing Analysis
17.7.2. Market Share Analysis, 2021
17.7.2.1. By Type
17.7.2.2. By End Use
17.7.2.3. By Application
17.7.2.4. By End Use
17.8. France
17.8.1. Pricing Analysis
17.8.2. Market Share Analysis, 2021
17.8.2.1. By Type
17.8.2.2. By End Use
17.8.2.3. By Application
17.8.2.4. By End Use
17.9. U.K.
17.9.1. Pricing Analysis
17.9.2. Market Share Analysis, 2021
17.9.2.1. By Type
17.9.2.2. By End Use
17.9.2.3. By Application
17.9.2.4. By End Use
17.10. Spain
17.10.1. Pricing Analysis
17.10.2. Market Share Analysis, 2021
17.10.2.1. By Type
17.10.2.2. By End Use
17.10.2.3. By Application
17.10.2.4. By End Use
17.11. Russia
17.11.1. Pricing Analysis
17.11.2. Market Share Analysis, 2021
17.11.2.1. By Type
17.11.2.2. By End Use
17.11.2.3. By Application
17.11.2.4. By End Use
17.12. BENELUX
17.12.1. Pricing Analysis
17.12.2. Market Share Analysis, 2021
17.12.2.1. By Type
17.12.2.2. By End Use
17.12.2.3. By Application
17.12.2.4. By End Use
17.13. China
17.13.1. Pricing Analysis
17.13.2. Market Share Analysis, 2021
17.13.2.1. By Type
17.13.2.2. By End Use
17.13.2.3. By Application
17.13.2.4. By End Use
17.14. Japan
17.14.1. Pricing Analysis
17.14.2. Market Share Analysis, 2021
17.14.2.1. By Type
17.14.2.2. By End Use
17.14.2.3. By Application
17.14.2.4. By End Use
17.15. South Korea
17.15.1. Pricing Analysis
17.15.2. Market Share Analysis, 2021
17.15.2.1. By Type
17.15.2.2. By End Use
17.15.2.3. By Application
17.15.2.4. By End Use
17.16. India
17.16.1. Pricing Analysis
17.16.2. Market Share Analysis, 2021
17.16.2.1. By Type
17.16.2.2. By End Use
17.16.2.3. By Application
17.16.2.4. By End Use
17.17. Thailand
17.17.1. Pricing Analysis
17.17.2. Market Share Analysis, 2021
17.17.2.1. By Type
17.17.2.2. By End Use
17.17.2.3. By Application
17.17.2.4. By End Use
17.18. Malaysia
17.18.1. Pricing Analysis
17.18.2. Market Share Analysis, 2021
17.18.2.1. By Type
17.18.2.2. By End Use
17.18.2.3. By Application
17.18.2.4. By End Use
17.19. Indonesia
17.19.1. Pricing Analysis
17.19.2. Market Share Analysis, 2021
17.19.2.1. By Type
17.19.2.2. By End Use
17.19.2.3. By Application
17.19.2.4. By End Use
17.20. Australia
17.20.1. Pricing Analysis
17.20.2. Market Share Analysis, 2021
17.20.2.1. By Type
17.20.2.2. By End Use
17.20.2.3. By Application
17.20.2.4. By End Use
17.21. New Zealand
17.21.1. Pricing Analysis
17.21.2. Market Share Analysis, 2021
17.21.2.1. By Type
17.21.2.2. By End Use
17.21.2.3. By Application
17.21.2.4. By End Use
17.22. GCC Countries
17.22.1. Pricing Analysis
17.22.2. Market Share Analysis, 2021
17.22.2.1. By Type
17.22.2.2. By End Use
17.22.2.3. By Application
17.22.2.4. By End Use
18. Market Structure Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Market Share Analysis of Top Players
18.3.1. By Regional
18.3.2. By Type
18.3.3. By End Use
18.3.4. By Application
18.3.5. By End Use
19. Competition Analysis
19.1. Competition Deep Dive
19.1.1. Medtronic
19.1.1.1. Overview
19.1.1.2. Product Portfolio
19.1.1.3. Profitability by Market Segments
19.1.1.4. Sales Footprint
19.1.1.5. Strategy Overview
19.1.1.5.1. Marketing Strategy
19.1.1.5.2. Product Strategy
19.1.1.5.3. Channel Strategy
19.1.2. BALT USA LLC
19.1.2.1. Overview
19.1.2.2. Product Portfolio
19.1.2.3. Profitability by Market Segments
19.1.2.4. Sales Footprint
19.1.2.5. Strategy Overview
19.1.2.5.1. Marketing Strategy
19.1.2.5.2. Product Strategy
19.1.2.5.3. Channel Strategy
19.1.3. DePuy Synthes
19.1.3.1. Overview
19.1.3.2. Product Portfolio
19.1.3.3. Profitability by Market Segments
19.1.3.4. Sales Footprint
19.1.3.5. Strategy Overview
19.1.3.5.1. Marketing Strategy
19.1.3.5.2. Product Strategy
19.1.3.5.3. Channel Strategy
19.1.4. Biomerics
19.1.4.1. Overview
19.1.4.2. Product Portfolio
19.1.4.3. Profitability by Market Segments
19.1.4.4. Sales Footprint
19.1.4.5. Strategy Overview
19.1.4.5.1. Marketing Strategy
19.1.4.5.2. Product Strategy
19.1.4.5.3. Channel Strategy
19.1.5. Zeus Indutsrial Products, INC.
19.1.5.1. Overview
19.1.5.2. Product Portfolio
19.1.5.3. Profitability by Market Segments
19.1.5.4. Sales Footprint
19.1.5.5. Strategy Overview
19.1.5.5.1. Marketing Strategy
19.1.5.5.2. Product Strategy
19.1.5.5.3. Channel Strategy
19.1.6. Raumedic AG
19.1.6.1. Overview
19.1.6.2. Product Portfolio
19.1.6.3. Profitability by Market Segments
19.1.6.4. Sales Footprint
19.1.6.5. Strategy Overview
19.1.6.5.1. Marketing Strategy
19.1.6.5.2. Product Strategy
19.1.6.5.3. Channel Strategy
19.1.7. Concentric Medical, Inc
19.1.7.1. Overview
19.1.7.2. Product Portfolio
19.1.7.3. Profitability by Market Segments
19.1.7.4. Sales Footprint
19.1.7.5. Strategy Overview
19.1.7.5.1. Marketing Strategy
19.1.7.5.2. Product Strategy
19.1.7.5.3. Channel Strategy
19.1.8. Creganna Medical
19.1.8.1. Overview
19.1.8.2. Product Portfolio
19.1.8.3. Profitability by Market Segments
19.1.8.4. Sales Footprint
19.1.8.5. Strategy Overview
19.1.8.5.1. Marketing Strategy
19.1.8.5.2. Product Strategy
19.1.8.5.3. Channel Strategy
19.1.9. Vegamedical.eu
19.1.9.1. Overview
19.1.9.2. Product Portfolio
19.1.9.3. Profitability by Market Segments
19.1.9.4. Sales Footprint
19.1.9.5. Strategy Overview
19.1.9.5.1. Marketing Strategy
19.1.9.5.2. Product Strategy
19.1.9.5.3. Channel Strategy
19.1.10. Stryker
19.1.10.1. Overview
19.1.10.2. Product Portfolio
19.1.10.3. Profitability by Market Segments
19.1.10.4. Sales Footprint
19.1.10.5. Strategy Overview
19.1.10.5.1. Marketing Strategy
19.1.10.5.2. Product Strategy
19.1.10.5.3. Channel Strategy
19.1.11. phenox GmbH
19.1.11.1. Overview
19.1.11.2. Product Portfolio
19.1.11.3. Profitability by Market Segments
19.1.11.4. Sales Footprint
19.1.11.5. Strategy Overview
19.1.11.5.1. Marketing Strategy
19.1.11.5.2. Product Strategy
19.1.11.5.3. Channel Strategy
19.1.12. Penumbra, Inc.
19.1.12.1. Overview
19.1.12.2. Product Portfolio
19.1.12.3. Profitability by Market Segments
19.1.12.4. Sales Footprint
19.1.12.5. Strategy Overview
19.1.12.5.1. Marketing Strategy
19.1.12.5.2. Product Strategy
19.1.12.5.3. Channel Strategy
19.1.13. Integer Holdings Corporation
19.1.13.1. Overview
19.1.13.2. Product Portfolio
19.1.13.3. Profitability by Market Segments
19.1.13.4. Sales Footprint
19.1.13.5. Strategy Overview
19.1.13.5.1. Marketing Strategy
19.1.13.5.2. Product Strategy
19.1.13.5.3. Channel Strategy
19.1.14. Terumo Corporation
19.1.14.1. Overview
19.1.14.2. Product Portfolio
19.1.14.3. Profitability by Market Segments
19.1.14.4. Sales Footprint
19.1.14.5. Strategy Overview
19.1.14.5.1. Marketing Strategy
19.1.14.5.2. Product Strategy
19.1.14.5.3. Channel Strategy
19.1.15. Integra LifeSciences Corporation
19.1.15.1. Overview
19.1.15.2. Product Portfolio
19.1.15.3. Profitability by Market Segments
19.1.15.4. Sales Footprint
19.1.15.5. Strategy Overview
19.1.15.5.1. Marketing Strategy
19.1.15.5.2. Product Strategy
19.1.15.5.3. Channel Strategy
19.1.16. Biomerics
19.1.16.1. Overview
19.1.16.2. Product Portfolio
19.1.16.3. Profitability by Market Segments
19.1.16.4. Sales Footprint
19.1.16.5. Strategy Overview
19.1.16.5.1. Marketing Strategy
19.1.16.5.2. Product Strategy
19.1.16.5.3. Channel Strategy
19.1.17. Acandis GmbH
19.1.17.1. Overview
19.1.17.2. Product Portfolio
19.1.17.3. Profitability by Market Segments
19.1.17.4. Sales Footprint
19.1.17.5. Strategy Overview
19.1.17.5.1. Marketing Strategy
19.1.17.5.2. Product Strategy
19.1.17.5.3. Channel Strategy
19.1.18. Teleflex Incorporated
19.1.18.1. Overview
19.1.18.2. Product Portfolio
19.1.18.3. Profitability by Market Segments
19.1.18.4. Sales Footprint
19.1.18.5. Strategy Overview
19.1.18.5.1. Marketing Strategy
19.1.18.5.2. Product Strategy
19.1.18.5.3. Channel Strategy
19.1.19. Microvention Inc.
19.1.19.1. Overview
19.1.19.2. Product Portfolio
19.1.19.3. Profitability by Market Segments
19.1.19.4. Sales Footprint
19.1.19.5. Strategy Overview
19.1.19.5.1. Marketing Strategy
19.1.19.5.2. Product Strategy
19.1.19.5.3. Channel Strategy
20. Assumptions & Acronyms Used
21. Research Methodology